FastForward Innovations Ltd - Digital performance marketing company - Says its portfolio company EMMAC Life Sciences has secured a license for the distribution of medicinal products. EMMAC now has the ability to import, distribute and export medicinal products including medical cannabis for the domestic Swiss, EU and international market.
"This is another important milestone for Emmac and one that positions us well to meet the requirements of the domestic Swiss market as regulation evolves, and caters to the growing demand from international markets for high-quality medical cannabis. We continue to execute at pace, realising our vision of establishing Emmac as Europe's largest independent cannabis company, and shaping the future of medical cannabis," says Emmac Chief Executive Antonio Costanzo.
FastForward has a 2.3% stake in EMMAC.
Current stock price: 11.42 pence
Year-to-date change: up 41%
By Ife Taiwo; ifetaiwo@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.
